Strategy
We focus on investing in and building breakthrough biotech companies around cutting edge advances in life sciences. We collaborate with exceptional entrepreneurs and provide flexible, long term capital to help accelerate their ideas into important new treatments for patients.
Investment criteria
We are science led investors, focusing on innovative technologies in areas of high unmet need. With our transatlantic footprint we have deep-routed networks across Europe and North America to source the best opportunities that offer meaningful therapies for patients.
Focus
Novel therapeutics with first or best in class approach. We focus on investing in high impact science, with the potential to dramatically improve outcomes for patients.
Source
An experienced team with a proven track record along with established venture capital and biotech networks provide Arix with access to quality deals
Geography
Headquartered in London with an office in New York provides access to the best life science innovation across Europe and North America
Development Stage
Guided by the quality of the opportunity with a focus on late pre-clinical to clinical stage companies